Lupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The ...

Trump's threat of a 200% tariff on pharmaceutical products can have severe implications on Indian drugmakers, as exports to ...

Asian Paints sells stake in Akzo Nobel India, GAIL extends gas agreement, SEBI proposes new guidelines, companies announce ...

Global Pharma major Lupin Limited and Zentiva Group, a pan-European pharmaceutical company, have entered into a license and ...

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

It is indicated for various diseases including heumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

The move is part of Lupin's broader strategy to create a specialised consumer healthcare entity, particularly aimed at ...

Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...

Lupin and Zentiva announce a license and supply agreement for the commercialization of biosimilar Certolizumab Pegol across ...

Lupin Ltd has entered into a License and Supply Agreement with Zentiva, k.s., for commercialization of Lupin's biosimilar Certolizumab Pegol.

Pharmaceutical major Lupin Limited has announced the strategic spin-off of its consumer healthcare business, LupinLife ...

Lupin Limited announces the spin-off of its consumer healthcare division, LupinLife Consumer Healthcare Ltd., into a wholly ...